2014
DOI: 10.1186/s40635-014-0027-9
|View full text |Cite
|
Sign up to set email alerts
|

A simple and easy in vitro model to test the efficacy of IV lines' needleless connectors against contamination

Abstract: BackgroundHub colonization after manipulation is responsible for 29% to 60% of catheter-related bloodstream infections (C-RBSI). Prevention can be achieved by the use of hub connectors, but its efficacy is generally based on instillation of high concentrations of microorganisms, which do not reflect the real contamination in daily practice. Our purpose was to create an in vitro model lasting long enough to be used for the comparison of the efficacy between various connectors against contamination simulating th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…In the present study, we simulated the real practice of connector handling using a recent model created by our group. The model enabled us to detect differences between connectors in terms of efficacy for preventing the entry of microorganisms through the catheter by manipulating the connectors while instilling saline with a 0.05 McFarland solution of S. aureus , despite it has not been previously tested in the clinical setting, obviously for ethical reasons (22). We did not find statistically significant differences between NeutraClear® and MicroClave®, as the median time to positivity of BCBs closed with NeutraClear® and MicroClave® was 36.04 and 20.13 hours, respectively, (p = 0.09).…”
Section: Resultsmentioning
confidence: 99%
“…In the present study, we simulated the real practice of connector handling using a recent model created by our group. The model enabled us to detect differences between connectors in terms of efficacy for preventing the entry of microorganisms through the catheter by manipulating the connectors while instilling saline with a 0.05 McFarland solution of S. aureus , despite it has not been previously tested in the clinical setting, obviously for ethical reasons (22). We did not find statistically significant differences between NeutraClear® and MicroClave®, as the median time to positivity of BCBs closed with NeutraClear® and MicroClave® was 36.04 and 20.13 hours, respectively, (p = 0.09).…”
Section: Resultsmentioning
confidence: 99%